Clinical Trial Update: Distinction Risk of Severe Infection in Febrile Neutropenia After Chemotherapy

View source ↗

Summary

This completed clinical trial explored factors distinguishing the risk of severe infection in patients with febrile neutropenia after chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia

Snippet

Sponsor: University Hospital, Lille | Conditions: Febrile Neutropenia, Rule of Clinical Decision, Chemotherapy | Status: COMPLETED